Visana Health Study Shows $3,429 Savings, Proving ROI in Women's Care

MINNEAPOLIS, MN – March 11, 2026 – A landmark study is challenging the long-held perception of women’s health as a mere cost center for employers, suggesting it may instead be a powerful lever for strategic savings. Visana Health, a virtual clinic specializing in comprehensive women’s care, announced that its model reduces total healthcare costs by $3,429 per member within just six months. The findings, independently validated by the prominent consulting firm Optum Advisory, provide some of the strongest evidence to date that investing in whole-person women’s healthcare can yield a significant and rapid return on investment.

For years, employers and health plans have viewed women's health benefits primarily through the narrow lenses of maternity and fertility, often treating other complex conditions as ancillary costs. This new data suggests that a broader, more integrated approach is not only clinically superior but also fiscally responsible, a revelation that could reshape benefits design and healthcare spending priorities nationwide.

The Financial Case for Whole-Person Care

Women's health represents one of the largest cost categories for employers, rivaling spending on cardiometabolic and musculoskeletal conditions. Yet, the care women often receive is fragmented and episodic, leading to delayed diagnoses, redundant specialist visits, and a frequent escalation to high-cost, invasive procedures for conditions like endometriosis and uterine fibroids. Against this backdrop, Visana Health's study offers a compelling financial argument for a different approach.

The $3,429 per-member savings identified in the Optum-validated analysis were not incidental. They were driven primarily by a reduction in expensive facility visits, fewer specialty care appointments, and lower overall gynecologic spending. By intervening earlier and more comprehensively, the model appears to head off the cascade of costs associated with unmanaged or poorly managed chronic conditions.

"This landmark study demonstrates that Visana's value-based care model delivers world-class clinical outcomes for women while generating measurable ROI for our health plan and employer partners in just six months, a timeline that is virtually unprecedented in healthcare," said Joe Connolly, Co-Founder and CEO of Visana Health, in a statement. He emphasized that the findings prove that "investment in evidence-based women’s health is a clinically sound and fiscally responsible strategy for managing utilization and spending both short-term and long-term."

This positions comprehensive women’s health not as a supplemental benefit, but as a core component of any effective cost-management strategy, a paradigm shift for CFOs and benefits managers accustomed to seeing this demographic as a source of unpredictable expenses.

Beyond Reproduction: A New 'Virtual Medical Home' Model

At the heart of these financial outcomes is a clinical model that Visana Health calls a "virtual medical home." This approach fundamentally rethinks how care is delivered, moving away from a system that only engages during reproductive events to one that provides continuous, coordinated support across a woman's entire life—from menstruation through menopause and beyond.

The model focuses on complex, chronic conditions that are often misdiagnosed or inadequately treated in traditional settings, such as polycystic ovary syndrome (PCOS), endometriosis, perimenopause, and thyroid disorders. Instead of treating symptoms in isolation, Visana's clinicians address the interconnected hormonal, metabolic, and reproductive needs of the patient.

"When women receive coordinated, longitudinal intervention for complex conditions, outcomes improve and avoidable utilization declines," explained Chevon Rariy, MD, Chief Clinical Innovation Officer at Visana Health. "By organizing care around the whole person, rather than isolated symptoms, we’re reducing unnecessary specialist visits and procedures while navigating patients toward higher-quality, more appropriate care."

This integrated approach stands in contrast to a growing but often fragmented women's health technology market. While competitors like Maven Clinic and Tia have expanded access to virtual care, Visana's distinct focus on complex chronic needs, coupled with its validated cost-savings data, carves out a unique position. It makes a direct appeal to the financial decision-makers at health plans and large employers who are desperate for solutions that tackle the root causes of high spending.

The Critical Role of Data and Independent Validation

In a crowded market filled with bold claims, the rigor of the study's methodology and the credibility of its validator are crucial. The analysis was conducted by Optum Advisory, the consulting arm of healthcare giant UnitedHealth Group, lending it significant weight. While the affiliation with a major payer might raise questions of objectivity for some industry watchdogs, Optum's reputation in health economics and its use of sophisticated analytical methods are well-established.

The study employed a robust, two-part statistical method to ensure its findings were as accurate as possible. First, a propensity score-matched cohort design was used. This technique created a control group by finding commercially insured women who were nearly identical to Visana's patients in terms of their health risks, baseline costs, and pre-existing conditions. This step helps to ensure the comparison is apples-to-apples, minimizing the risk that the savings were simply because Visana attracted healthier patients.

Second, a difference-in-differences framework was applied to analyze the claims data. This method compared the change in healthcare costs for Visana members before and after they joined the program to the change in costs for the matched control group over the same period. This isolates the impact of Visana's intervention from broader trends in healthcare spending, strengthening the claim that the savings are directly attributable to its care model.

While this methodology is a gold standard for observational research, it has inherent limitations. It cannot fully account for unobserved differences between the groups, and its findings are based on a six-month window, leaving questions about long-term impact unanswered. However, for employers and health plans seeking evidence-based solutions, this level of validated data provides a powerful rationale for adoption, moving the conversation from promising concepts to proven results. The study sets a new bar for accountability in the digital health space, demonstrating the power of data to not only improve patient care but also build a compelling business case for innovation.